Had we not intervened, the hearing would have gone ahead with DEA openly tipping the scales against rescheduling.” By Michael ...

Bachtell is lined up to be chairman the U.S. Cannabis Roundtable, with backing from the "big five" legal U.S. cannabis multi-state operators including Cresco Labs, Verano Holdings Corp. (VRNOF), ...

The Justice Department is telling a federal court that it should pause a lawsuit challenging the Drug Enforcement ...

From medical use to recreation, lawmakers are floating a raft of cannabis legislation at the statehouse. But can it pass?

The federal government labels marijuana as a schedule one drug in the same category as LSD, peyote and heroin. An effort to ...

A last-minute Biden administration effort to loosen restrictions on marijuana by rescheduling, or reclassifying it, as a less ...

A suspected fentanyl dealer in Baton Rouge is behind bars and thousands of lethal doses of the drug and several other ...

Company views delay as imperative administrative step and symbolic win for industry against conflicted DEA – – Company condemns agency wrongdoing and commends judge for harsh criticism of government ...

The Fresh Toast - As thousands of small business await a ruling, the DEA causes another delay in marijuana rescheduling.

DEA cancels hearing on marijuana rescheduling amid legal challenge, delaying reform for at least three months. Read more here ...

DEA Administrative Law Judge John Mulrooney has canceled the first hearings on the proposal to reschedule cannabis to a Schedule III drug after ...

AdvisorShares Pure US Cannabis, a popular exchange-traded fund tracking marijuana stocks, slid 3.6% to $3.44 on Thursday, hovering near an all-time low hit the day before. Shares of the biggest ...